Department of Pharmaceutics, PLA General Hospital , Beijing , China.
Drug Dev Ind Pharm. 2014 Apr;40(4):452-7. doi: 10.3109/03639045.2013.767829. Epub 2013 Apr 8.
To evaluate the effects of various additives or polymers on the in vitro characteristics of nerve growth factor (NGF) microspheres.
NGF microspheres were fabricated using polyethylene glycol (PEG), ovalbumin (OVA), bovine serum albumin (BSA) or glucose as protein protectors, and poly(lactide-co-glycolide) (PLGA) or poly(lactic acid) (PLA)/PLGA blends as encapsulation materials.
Encapsulation efficiencies of the NGF microspheres with various additives or polymers were not more than 30%. A comparative study revealed that OVA was somewhat superior over others, and was thus chosen as the protective additive in subsequent experiments. Polymer analysis showed that NGF release from 1:1 PLA (η = 0.8):PLGA (75/25, η = 0.45) microspheres lasted for 90 d with a burst release rate of 12.7%. About 40% of the original bioactivity was retained on the 28th day, while 10% was left on the 90th day.
The combination of OVA as an additive and the PLA/PLGA blend as the coating matrix is suitable for encapsulation of NGF in microspheres for extended release.
评估各种添加剂或聚合物对神经生长因子(NGF)微球体外特性的影响。
使用聚乙二醇(PEG)、卵清蛋白(OVA)、牛血清白蛋白(BSA)或葡萄糖作为蛋白质保护剂,聚(乳酸-共-乙醇酸)(PLGA)或聚乳酸(PLA)/PLGA 共混物作为包封材料制备 NGF 微球。
具有各种添加剂或聚合物的 NGF 微球的包封效率不超过 30%。对比研究表明,OVA 略优于其他物质,因此被选为后续实验中的保护添加剂。聚合物分析表明,1:1 PLA(η=0.8):PLGA(75/25,η=0.45)微球中 NGF 的释放持续 90d,突释率为 12.7%。第 28 天保留了约 40%的原始生物活性,第 90 天保留了 10%。
OVA 作为添加剂与 PLA/PLGA 共混物作为涂层基质的结合适用于 NGF 微球的包封,以实现延长释放。